CFG
VRTX icon

Cooper Financial Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Cooper Financial Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61M Buy
5,261
+662
+14% +$293K 0.22% 86
2026
Q1 		$2.05M Sell
4,599
-742
-14% -$346K 0.21% 92
2025
Q4 		$2.42M Buy
5,341
+3,021
+130% +$1.3M 0.26% 69
2025
Q3 		$909K Sell
2,320
-1,324
-36% -$553K 0.1% 157
2025
Q2 		$1.62M Sell
3,644
-993
-21% -$458K 0.19% 92
2025
Q1 		$2.25M Sell
4,637
-45
-1% -$21K 0.3% 64
2024
Q4 		$1.89M Buy
4,682
+651
+16% +$302K 0.23% 84
2024
Q3 		$1.87M Buy
4,031
+284
+8% +$136K 0.24% 73
2024
Q2 		$1.76M Buy
3,747
+120
+3% +$52.1K 0.26% 71
2024
Q1 		$1.52M Buy
3,627
+400
+12% +$169K 0.25% 80
2023
Q4 		$1.31M Buy
3,227
+207
+7% +$76.5K 0.24% 79
2023
Q3 		$1.05M Buy
3,020
+29
+1% +$10.1K 0.25% 98
2023
Q2 		$1.05M Buy
2,991
+297
+11% +$100K 0.26% 89
2023
Q1 		$849K Buy
2,694
+230
+9% +$69K 0.23% 107
2022
Q4 		$712K Buy
2,464
+466
+23% +$142K 0.22% 111
2022
Q3 		$579K Buy
1,998
+917
+85% +$264K 0.21% 116
2022
Q2 		$305K Buy
1,081
+122
+13% +$32.7K 0.11% 180
2022
Q1 		$250K Buy
959
+22
+2% +$5.22K 0.1% 202
2021
Q4 		$206K Buy
+937
New +$182K 0.08% 225

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Cooper Financial Group's VRTX Position: Q2 2026 in Review

Cooper Financial Group increased its Vertex Pharmaceuticals (VRTX) stake by 14% in Q2 2026, buying an estimated $293K and bringing the position to 5,261 shares worth $2.61M. The position accounts for 0.22% of the portfolio, ranked #86.

Cooper Financial Group first reported a position in VRTX in Q4 2021 and has held it in 19 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Cooper Financial Group held 5,261 shares of Vertex Pharmaceuticals worth $2.61M as of Q2 2026.
  • Cooper Financial Group bought 662 Vertex Pharmaceuticals shares in Q2 2026, an estimated $293K.
  • Vertex Pharmaceuticals made up 0.22% of Cooper Financial Group's portfolio in Q2 2026, its #86 holding.
  • Cooper Financial Group first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Cooper Financial Group's 13F filing for Q2 2026, filed 8 Jul 2026.